Definium Therapeutics Inc (DFTX) PT Raised to $50 at Needham
Significant upside implied by target above current price; bullish setup.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Significant upside implied by target above current price; bullish setup.
What happened, with direct paths to the underlying reporting
Needham raises target to $50; current price $36.67.
Target: $50
Posted price: $36.67
Analyst firm: Needham
Analyst: Ami Fadia
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.